scholarly article | Q13442814 |
P2093 | author name string | Pedro Geraldes | |
Jeffrey L Platt | |||
Cody A Koch | |||
P2860 | cites work | Establishment in culture of pluripotential cells from mouse embryos | Q27860625 |
Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells | Q29547491 | ||
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites | Q36376598 | ||
P433 | issue | 1 | |
P921 | main subject | immunosuppression | Q1455316 |
P304 | page(s) | 89-98 | |
P577 | publication date | 2007-10-25 | |
P1433 | published in | Stem Cells | Q15724411 |
P1476 | title | Immunosuppression by embryonic stem cells. | |
P478 | volume | 26 |
Q37742101 | Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies |
Q41853000 | Bone marrow-derived cells homing for self-repair of periodontal tissues: a histological characterization and expression analysis |
Q36998531 | CD70-CD27 ligation between neural stem cells and CD4+ T cells induces Fas-FasL-mediated T-cell death |
Q37610499 | Cells derived from iPSC can be immunogenic - yes or no? |
Q33690008 | Concise review: mesenchymal stromal cells used for periodontal regeneration: a systematic review |
Q41852461 | Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation |
Q39262859 | Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice. |
Q35473934 | Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells |
Q89986366 | Embryonic stem cell extracts improve wound healing in diabetic mice |
Q41853497 | Embryonic stem cell therapy of heart failure in genetic cardiomyopathy |
Q34193128 | Embryonic stem cell-derived factors inhibit T effector activation and induce T regulatory cells by suppressing PKC-θ activation |
Q26770126 | Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation |
Q33564357 | Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells |
Q41831145 | Expression of major histocompatibility complex class I proteins and their antigen processing chaperones in mouse embryonic stem cells from fertilized and parthenogenetic embryos |
Q30828462 | F4/80+ Host Macrophages Are a Barrier to Murine Embryonic Stem Cell-Derived Hematopoietic Progenitor Engraftment In Vivo |
Q37295081 | Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression |
Q35624098 | Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1 |
Q54415459 | Human embryonic stem cell-extracts inhibit the differentiation and function of monocyte-derived dendritic cells. |
Q21245470 | Human embryonic stem cells hemangioblast express HLA-antigens |
Q37372183 | Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives |
Q36040255 | Hurdles to clinical translation of human induced pluripotent stem cells |
Q47787334 | Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells |
Q38113726 | Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives |
Q36802900 | Immunogenicity of pluripotent stem cells and their derivatives |
Q35957485 | Immunological Properties of Corneal Epithelial-Like Cells Derived from Human Embryonic Stem Cells |
Q41242617 | Immunological Properties of Murine Parthenogenetic Stem Cells and Their Differentiation Products |
Q34774684 | Immunological barriers to stem-cell based cardiac repair |
Q41998193 | Immunological properties of embryonic and adult stem cells |
Q84257326 | Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response |
Q36861712 | Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts |
Q37861021 | In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages. |
Q43161029 | In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation |
Q39040578 | Induced pluripotent stem cell technology: a decade of progress |
Q48254157 | Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice. |
Q35155712 | Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro |
Q40059574 | Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy |
Q43169329 | MFG-E8 Is Critical for Embryonic Stem Cell-Mediated T Cell Immunomodulation. |
Q37350071 | Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules. |
Q34352877 | Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts |
Q34330274 | New and old technologies for organ replacement. |
Q35876527 | Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo |
Q37863548 | Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations. |
Q35234014 | Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells |
Q28600945 | Restoration of a Critical Mandibular Bone Defect Using Human Alveolar Bone-Derived Stem Cells and Porous Nano-HA/Collagen/PLA Scaffold |
Q61959986 | Role of the Kynurenine Pathway in Stem Cell Biology |
Q38175402 | Specific protein markers for stem cell cross-talk with neighboring cells in the environment |
Q26861615 | Stem cell imaging: from bench to bedside |
Q30381054 | Stem cell platforms for regenerative medicine |
Q38003187 | Stem cells in the reproductive system |
Q38040207 | Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury. |
Q39709204 | The immunosuppressive effect of embryonic stem cells and mesenchymal stem cells on both primary and secondary alloimmune responses |
Q38149123 | The kynurenine pathway in stem cell biology. |